Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 3 studies | 24% ± 2% | |
| glutamatergic neuron | 3 studies | 44% ± 11% |
Insufficient scRNA-seq data for expression of XKR9 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 69% | 20.37 | 225 / 328 | 68% | 2.50 | 121 / 178 |
| stomach | 80% | 42.39 | 288 / 359 | 52% | 2.14 | 150 / 286 |
| lung | 68% | 33.26 | 393 / 578 | 61% | 2.19 | 710 / 1155 |
| ovary | 79% | 23.28 | 142 / 180 | 47% | 1.18 | 202 / 430 |
| adrenal gland | 100% | 109.50 | 257 / 258 | 15% | 0.34 | 35 / 230 |
| bladder | 71% | 41.00 | 15 / 21 | 43% | 1.28 | 218 / 504 |
| esophagus | 65% | 17.83 | 936 / 1445 | 50% | 2.14 | 91 / 183 |
| intestine | 64% | 38.71 | 620 / 966 | 49% | 1.87 | 260 / 527 |
| liver | 79% | 145.33 | 179 / 226 | 34% | 0.94 | 137 / 406 |
| uterus | 62% | 17.03 | 105 / 170 | 46% | 1.20 | 209 / 459 |
| prostate | 85% | 36.89 | 209 / 245 | 21% | 0.36 | 105 / 502 |
| breast | 73% | 32.76 | 333 / 459 | 25% | 0.72 | 276 / 1118 |
| skin | 72% | 40.94 | 1308 / 1809 | 18% | 0.42 | 86 / 472 |
| thymus | 73% | 26.33 | 476 / 653 | 13% | 0.20 | 77 / 605 |
| brain | 80% | 32.30 | 2111 / 2642 | 5% | 0.08 | 36 / 705 |
| kidney | 65% | 16.71 | 58 / 89 | 18% | 0.36 | 166 / 901 |
| adipose | 65% | 20.51 | 787 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 63% | 18.76 | 847 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 59% | 13.03 | 142 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 53% | 1.32 | 24 / 45 |
| heart | 50% | 12.36 | 431 / 861 | 0% | 0 | 0 / 0 |
| muscle | 49% | 11.57 | 395 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 24% | 8.01 | 222 / 929 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 7% | 0.09 | 2 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_1902742 | Biological process | apoptotic process involved in development |
| GO_0043652 | Biological process | engulfment of apoptotic cell |
| GO_0070782 | Biological process | phosphatidylserine exposure on apoptotic cell surface |
| GO_0005886 | Cellular component | plasma membrane |
| Gene name | XKR9 |
| Protein name | XK-related protein XK-related protein 9 (hXKR9) [Cleaved into: XK-related protein 9, processed form] |
| Synonyms | XRG9 |
| Description | FUNCTION: [XK-related protein 9, processed form]: Phospholipid scramblase that promotes phosphatidylserine exposure on apoptotic cell surface . Phosphatidylserine is a specific marker only present at the surface of apoptotic cells and acts as a specific signal for engulfment . . |
| Accessions | ENST00000520092.5 E5RI45 ENST00000519350.1 Q5GH70 E5RFF6 ENST00000520030.5 ENST00000408926.8 |